Department of Medicine – Speaking on COVID-19
On the front lines: Intensive care physician Patrick Aguilar
5 Questions with William G. Powderly, MD
Clinical trial launches to evaluate antimalarial drugs for COVID-19 treatment
by Julia Evangelou Strait April 9, 2020
Washington University School of Medicine in St. Louis is launching a clinical trial for patients hospitalized with COVID-19 at Barnes-Jewish Hospital. The trial will investigate the effectiveness of different combinations of the antimalarial drugs chloroquine and hydroxychloroquine and the antibiotic azithromycin in treating ill patients infected with the novel coronavirus.
That Guy – A COVID Public Health Announcement
Staying Safe from Respiratory Viral Infections
Dr. Patrick Aguilar, director of Medical Critical Care at BJH and WUSM, discusses personal protective equipment and provides guidance to keep our staff and patients safe.
Department of Medicine Clinic Director Adapts FEMA Guidelines in Light of COVID-19
Just six weeks on the job, Jennifer Schmidt, MD, medical director at the Washington University Complete Care Clinic, found herself preparing to cope with the demands of COVID-19. As a trained clinician, she turned to guidelines, and has adapted the Federal Emergency Management Agency’s Incident Command System to manage the clinic’s operations during this fast-changing COVID-19 pandemic. Her approach is featured in the New England Journal of Medicine’s Catalyst, “Seeking Evidence-Based COVID-19 Preparedness: A FEMA Framework for Clinic Management.” Read the full article here.
Dr. Hilary Babcock, an infectious disease specialist at Washington University School of Medicine and BJC’s director of infection prevention, shares some important information about coronavirus.
Department of Medicine, Division of Infectious Diseases faculty are working to answer questions about coronavirus in the community. View Hilary Babcock, MD, MPH, Professor of Medicine, Division of Infectious Diseases, School of Medicine, interview on KMOV News 4.